Cancer

The interplay between cancer and antimicrobial resistance

Infections are the second leading cause of death in cancer patients, after the cancer itself; Zisis Kozlakidis and Shalini Jayasekar Zurn discuss the challenges surrounding the interplay between cancer and antimicrobial resistance (AMR).

The interplay between cancer and antimicrobial resistance

Infections are the second leading cause of death in cancer patients, after the cancer itself; Zisis Kozlakidis and Shalini Jayasekar Zurn discuss the challenges surrounding the interplay between cancer and antimicrobial resistance (AMR).

Epigenetic map creates new insights into the cause of cancer and dementia

A new project is expected to help us understand diseases such as cancer and dementia. A major partnership involving Oxford Nanopore Technologies, UK Biobank, NHS England, Genomics England, and the UK government has made this possible.

DigiTrials: NHS patients will be contacted to volunteer for cancer research trials

The NHS is looking for volunteers as part of the three cancer projects that have been selected as part of the NHS DigiTrials initiative. Almost 150,000 volunteers will take part in these trials to help transform cancer treatment.

Diagnosing efficiency: How detailed analysis drives NHS cancer care improvements

Gareth Jenkins, a partner at Changeology Group Ltd, discusses the potential of detailed analysis to enhance the efficiency of cancer care within the NHS.

Leading the charge in cancer care: How innovation and collaboration are helping to clear the NHS cancer backlog

Driven by personal loss, this healthcare leader shares how their organisation (SAH Diagnostics) partners with the NHS, combining innovation and clinical excellence to reduce NHS cancer backlogs and improve patient outcomes in an exclusive interview with Open Access Government.

UK initiatives aim to transform cancer care with new technologies

To revolutionise cancer treatment and diagnosis the UK government has revealed plans in partnership with pharmaceutical companies and universities.

Ultrasound test that detects ovarian cancer

Researchers have identified a new tool for detecting ovarian cancer in postmenopausal women.

Miniature scanner promises game-changing medical imaging

Researchers at University College London (UCL) have developed a miniature scanner that could transform the way doctors diagnose and manage diseases such as cancer, diabetes, and arthritis.

Using AI to personalise treatments for veterans with rectal cancer

Researchers at Case Western Reserve University and the Louis Stokes Cleveland VA Medical Center have secured a four-year, $1.14 million grant from the U.S. Department of Veterans Affairs.

Leeds Teaching Hospitals NHS Trust pilots AI tool to transform prostate cancer diagnosis

Leeds Teaching Hospital NHS Trust (LTHT) is testing a new artificial intelligence tool (AI) to revolutionise prostate cancer diagnosis.

How NHS cancer care is adapting post-pandemic

Asal Shirazi, Founder and CEO of the Autoimmune Support and Awareness (ASA) Foundation, discusses the increased prevalence of cancer in the UK and the challenges facing NHS England as it works to tackle backlogs in cancer care.

Cancer backlogs: Why money alone isn’t the answer

As the UK’s healthcare system continues to struggle with care and cancer backlogs, Gareth Jenkins of Changeology Group Ltd explains how the company can assist healthcare teams in making positive operational changes that enhance efficiency and patient outcomes.

Vaccine-preventable cancers through cooperation

Milena Angelova, EESC member and Rapporteur for the EESC opinion on Vaccine-preventable cancers, highlights the vital role of civil society in eradicating them.

First ever early pancreatic cancer diagnosis

Researchers have unveiled a pioneering method that could revolutionise the early detection of pancreatic cancer, a disease known for its late diagnosis and low survival rates.

Routine blood tests could speed up cancer diagnosis for people with stomach pain or bloating

A new study led by researchers at University College London (UCL) suggests that routine blood tests could significantly enhance early cancer diagnosis for individuals experiencing stomach pain or bloating.

Combining prostate cancer treatments raises heart disease risk

New research highlights a crucial consideration for men battling prostate cancer, a potentially heightened risk of heart disease when certain medications are combined.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders